Anthem Blue Cross and Blue Shield | CommercialJanuary 16, 2025
Kidney Health Evaluation for Patients With Diabetes (KED) 2025
HEDIS® is a widely used set of performance measures developed and maintained by the National Committee for Quality Assurance (NCQA). These are used to drive improvement efforts surrounding best practices.
HEDIS measure
This measure evaluates patients 18 to 85 years old with diabetes (type 1 and type 2) who received a kidney health evaluation, defined by an estimated glomerular filtration rate (eGFR) and a urine albumin-creatinine ratio (uACR) during the measurement year.
Refer to attachment to view full details
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Maine, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
MULTI-BCBS-CM-075546-24-CPN74985
ATTACHMENTS: Kidney Health Evaluation for Patients With Diabetes (KED) 2025 - Blue Cross Blue Shield (pdf - 0.4mb)
To view this article online:
Or scan this QR code with your phone